UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis

Life sciences (1973), 2021-07, Vol.276, p.119399-119399, Article 119399

2021

Volltextzugriff (PDF)

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

Journal of hematology and oncology, 2016-04, Vol.9 (37), p.34-7, Article 34

2016

Volltextzugriff (PDF)

ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

Journal of hematology and oncology, 2015-11, Vol.8 (129), p.129-129, Article 129

2015

Volltextzugriff (PDF)

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1501-1511

2021

Volltextzugriff (PDF)

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Cancer cell, 2022-03, Vol.40 (3), p.277-288.e3

2022

Volltextzugriff (PDF)

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Journal of hematology and oncology, 2010-02, Vol.3 (1), p.5-5, Article 5

2010

Volltextzugriff (PDF)

Novel CD20 monoclonal antibodies for lymphoma therapy

Journal of hematology and oncology, 2012-10, Vol.5 (1), p.64-64, Article 64

2012

Volltextzugriff (PDF)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis

Frontiers in oncology, 2020-11, Vol.10, p.570654-570654

2020

Volltextzugriff (PDF)

An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma

Frontiers in immunology, 2022-02, Vol.13, p.839901-839901

2022

Volltextzugriff (PDF)

Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives

Frontiers in oncology, 2024-07, Vol.14, p.1378647

2024

Volltextzugriff (PDF)

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial

Molecular cancer, 2022-01, Vol.21 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

Translational oncology, 2023-09, Vol.35, p.101723-101723, Article 101723

2023

Volltextzugriff (PDF)

Novel agents for advanced pancreatic cancer

Oncotarget, 2015-11, Vol.6 (37), p.39521-39537

2015

Volltextzugriff (PDF)

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer

Journal of hematology and oncology, 2009-06, Vol.2 (1), p.22-22, Article 22

2009

Volltextzugriff (PDF)

Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection

Frontiers in surgery, 2023-01, Vol.9, p.905437-905437

2023

Volltextzugriff (PDF)

Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma

Clinical and translational medicine, 2023-11, Vol.13 (11), p.e1478-n/a

2023

Volltextzugriff (PDF)

Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data

Frontiers in oncology, 2020-12, Vol.10, p.526577

2020

Volltextzugriff (PDF)

Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation

Experimental hematology & oncology, 2020-06, Vol.9 (1), p.12-12, Article 12

2020

Volltextzugriff (PDF)

High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray

Oncology letters, 2020-09, Vol.20 (3), p.2356-2368

2020

Volltextzugriff (PDF)

hnRNPA1 promotes the metastasis and proliferation of gastric cancer cells through WISP2-guided Wnt/β-catenin signaling pathway

Discover. Oncology, 2024-09, Vol.15 (1), p.465-11, Article 465

2024

Volltextzugriff (PDF)

LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin

Biomarker research, 2024-02, Vol.12 (1), p.19-19, Article 19

2024

Volltextzugriff (PDF)

P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia

Journal of hematology and oncology, 2008-10, Vol.1 (1), p.15-15, Article 15

2008

Volltextzugriff (PDF)

A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma

Cancer management and research, 2018-01, Vol.10, p.1507-1515

2018

Volltextzugriff (PDF)

DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation

Cancer biology & medicine, 2023-12, Vol.21 (3), p.1-15

2023

Volltextzugriff (PDF)

Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells

Journal of hematology and oncology, 2016-01, Vol.9 (3), p.3-3, Article 3

2016

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(88)
Newsletter-Artikel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(68)
Oncology
(51)
Humans
(43)
Hematology
(13)
Prognosis
(13)
Respiratory System
(13)
Lung Neoplasms - Drug Therapy
(12)
Metastasis
(11)
Lung Neoplasms - Genetics
(10)
Male
(10)
Tumors
(10)
Antineoplastic Agents - Pharmacology
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Apoptosis
(9)
Care And Treatment
(9)
Proteins
(9)
Review
(9)
Cancer
(8)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Novel CD20 monoclonal antibodies for lymphoma therapy

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis

An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma

Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial

MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

Novel agents for advanced pancreatic cancer

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer

Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection

Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma

Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data

Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation

High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray

hnRNPA1 promotes the metastasis and proliferation of gastric cancer cells through WISP2-guided Wnt/β-catenin signaling pathway

LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin

P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia

A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma

DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation

Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells

Suchergebnisse filtern